Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Miscellaneous
Patent
1993-02-26
1998-06-30
Isabella, David
Prosthesis (i.e., artificial body members), parts thereof, or ai
Miscellaneous
623 11, 623 2, A61F 202
Patent
active
057726957
ABSTRACT:
Tissue which is suitable for transplant is treated with a growth factor and cells which populate the tissue and native cells must be removed, they cannot be "masked" reduce immunogenicity; this increases the longevity of the tissue upon transplant. The preferred growth factor is basic fibroblast growth factor, and the preferred cells are fibroblasts. The tissue can be an allograft or xenograft taken from a cow, pig or other mammal.
REFERENCES:
patent: 3966401 (1976-06-01), Hancock et al.
patent: 4240794 (1980-12-01), Holman et al.
patent: 4323358 (1982-04-01), Lentz et al.
patent: 4378224 (1983-03-01), Nimni et al.
patent: 4383832 (1983-05-01), Fraefel et al.
patent: 4402697 (1983-09-01), Pollock et al.
patent: 4405327 (1983-09-01), Pollock
patent: 4407787 (1983-10-01), Stemberger
patent: 4485096 (1984-11-01), Bell
patent: 4539716 (1985-09-01), Bell
patent: 4546500 (1985-10-01), Bell
patent: 4553974 (1985-11-01), Dewanjee
patent: 4559298 (1985-12-01), Fahy
patent: 4567847 (1986-02-01), Linner
patent: 4609551 (1986-09-01), Caplan
patent: 4642120 (1987-02-01), Nevo et al.
patent: 4647283 (1987-03-01), Carpentier et al.
patent: 4648881 (1987-03-01), Carpentier et al.
patent: 4688387 (1987-08-01), Conaway
patent: 4707998 (1987-11-01), Linner et al.
patent: 4776853 (1988-10-01), Klement et al.
patent: 4785079 (1988-11-01), Gospodarowicz
patent: 4798611 (1989-01-01), Freeman, Jr.
patent: 4799361 (1989-01-01), Linner
patent: 4801299 (1989-01-01), Brendel et al.
patent: 4828563 (1989-05-01), Muller-Lierheim
patent: 4835102 (1989-05-01), Bell et al.
patent: 4838888 (1989-06-01), Nashef
patent: 4865871 (1989-09-01), Livesey et al.
patent: 4870160 (1989-09-01), Charonis et al.
patent: 4878913 (1989-11-01), Aebischer et al.
patent: 4890457 (1990-01-01), McNally et al.
patent: 4902782 (1990-02-01), Gospodarowicz
patent: 4911710 (1990-03-01), Milthorpe et al.
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4960424 (1990-10-01), Grooters
patent: 4964280 (1990-10-01), Piunno et al.
patent: 4973493 (1990-11-01), Guire
patent: 5000963 (1991-03-01), Hefton
patent: 5002566 (1991-03-01), Carpentier et al.
patent: 5131850 (1992-07-01), Brockbank
patent: 5145770 (1992-09-01), Tubo et al.
patent: 5192312 (1993-03-01), Orton
patent: 5197985 (1993-03-01), Caplan et al.
patent: 5215541 (1993-06-01), Nashef et al.
patent: 5219576 (1993-06-01), Chu et al.
patent: 5336616 (1994-08-01), Livesey et al.
patent: 5474770 (1995-12-01), Broly et al.
O'Brien, et al. A Comparison of Aortic Valve Replacement with Viable Cryopreserved and Fresh Allograft Valves, with a Note on Chromosomal Studies, J. Thoracic & Cardiovascular Surg. 94:812-823 (1987).
Slavkin , et al., Concepts of Epithelial-Mesenchymal Interactions During Development: Tooth and Lung Organogenesis, J. Cellular Bioch. 26:117-125 (1984).
Manu-Tawiah and Martin, Peat Extract as a Carbon Source for the Growth of Pleurotus ostreatus Mycelium, J. Sci. Food Agric. 47:243-247 (1989).
Nichols, et al., Cytogenetic Evaluation of Human Endothelial Cell Cultures, C. Cellular Phys. 132:453-462 (1987).
Nanchahal, et al., Cultured Composite Skin Grafts: Biological Skin Equivalents Permitting Massive Expansion, The Lancet 2 (1989) 22:191-193 (Jul. 22, 1989).
Shiogama, et al., An Improved Cryopreservation Procedure for Human Fetal Pancreas Tissues, Biological Abstracts, vol. 85, Abstract No. 46563 (1988).
Shingh, et al., Binding of Tumor-Derived Angiogenic Factor to High Affinity Receptor on Endothelial Cells, J. Cell Biology 103:299a, Abstract No. 1107 (1986).
Bell, et al., Living Tissue Formed in vitro and Accepted as Skin-Equivalent Tissue of Full Thickness, Science 211:1052-1054 (1981).
Weinberg and Bell, A Blood Vessel Model Constructed from Collagen and Cultured Vascular Cells, Science 231:397-400 (1986).
Kent, et al., Species Variation and the Success of Endothelial Seeding, J. Vascular Surg. 9:271-276 (1989).
Hoch, et al., In vitro Endothelialization of an Aldehyde-Stabilized Native Vessel, J. Surg. Res. 44:545-554 (1988).
Noyes, Culture of Human Fetal Liver, Proc. Soc. Exp. Biol. Med. 144:245-248 (1973).
Leapman, et al., Transplantation of Fetal Intestine: Survival and Function in a Subcutaneous Location in Adult Animals, Ann. Surg. 179:109-114 (1974).
Brockbank, Repopulation of Xenograft Heart Valves with Fibroblasts, Small Business Innovation Research Grant Application No. PHS 90-2 (submitted Aug. 15, 1990).
"Porcine Heterograft Valve Replacement in Children", by D.B. Wiliams, MD, G.K. Danielson, MD, D.C. McGoon, MD, F.J. Puga, MD, D.D. Mair, MD and W.D. Edwards MD, J. Thorac Cardiovasc Surg 84: pp. 446-450, Sep. 1982.
"Mechanical Testing of Cryopreserved Aortic Allografts Comparison with Xenografts and Fresh Tissue", by I. Vesely, PhD, L.Gonzalez-Lavin, MD, D. Graf and D. Goughner, MD, PhD, FRCPC, Journal of Thoracic and Cardiovascular Surgery, St. Louis, vol. 99, No. 1, pp. 119-123, Jan. 1990.
"An Approach to the Optimization of Preparation of Bioprosthetic Heart Valves", by D. Mavrilas and Yannis Missirlis, J. Biomechanics, vol. 24, No. 5 pp. 331-339, 1991.
Residual Heteroantigencity of Glutaraldehyde-Treated Porcine Cardiac Valves, by M.L. Villa, S. DeBiasi and F. Pilotto, Tissue Antigens, vol. 16, pp. 62-29, 1980.
"Tissue-Derived Biomaterials and Their Use in Cardiovascular Prosthetic Devices", by S.L. Hilbert, V.J. Ferrans, and M. Jones, Medical Progress Through Techology, vol. 14, pp. 115-153, 1988.
"Characterization of Pepsin-Solubilized Bovine Heart-Valve Collagen", by R.I. Bashey, H.M. Bashey and S.A. Jimenez, Biochem Journal, vol. 173, pp. 885-894, 1978.
"Collagen Heterogeneity in Pig Heart Valves", by P. Mannschott, D. Herbage, M. Weiss and C. Buffevant, Biochimica et Biophysica Acts, vol. 434, pp. 177-183, 1976.
"Preservation of Aortic Heart Valves with Maintenance of Cell Viability", by A.W. M. Van Der Kamp, MD, W.J. Visser, J.M. Van dongen, Ph.D., J. Nauta, MD and H. Galjaard, MD, Journal of Surgical Research, vol. 30, pp. 47-56, 1981.
"Viability of Connective Tissue Cells Following Storage of Aortic Valve Leaflets", by D.D. Reichenbach, MD, H. Mohri, MD, M. Sands and K.A. Merendino, MD, Journal of Thoracic and Cardiovascular Surgery, vol. 62, No. 5, pp. 690-695, Nov. 1971.
"Aortic Valve Replacement with Frozen Irradiated Homografts", by P. M. Beach, Jr., MD, F.O. Bowman, Jr., MD, G.A. Kaiser, MD, E. Parodi, MD and J.R. Malm, MD, Department of Surgery, College of Physicians and Surgeons, Columbia University, Supplement I to Circulation, vols. XLV and XLVI, pp. I-29-I 35, May 1972.
"Histological Assessment of Orthotopic Aortic Valve Leaflet Allografts: Its Role in Selecting Graft Pre-Treatment" by L.C. Armiger, J.B. Gavin and B.G. Barratt-Boyes, Pathology, vol. 15, pp. 67-73, 1983.
"A Comparison of Aortic Valve Replacement with Viable Cryopreserved and Fresh Allograft Valves, With a Note on Chromosomal Studies", by M.F. O'Brien, FRACS, FRCS, E. G. Stafford, FRACS, FACS, M.A.H. Gardner, FRACS, P.G. Pohlner, FRACS, D.C. McGiffin, FRACS, J.W. Kirklin, MD, Journal of Thoracic and Cardiovasular Surgery, vol. 94, No. 6, pp. 812-823, Dec. 1987.
"Cryopreserved Viable Allograft Aortic Valves", by M.F. O'Brien, E.G. Stafford, M.A. H. Gardner, P. Pohlner, D.C. McGrinnin, M. Johnston, P. Tesar, A. Brosnan, P. Duffy, (Prince Charles Hospital), Brisbane, Australia, pp. 311-321.
"The Viable Cryopreserved Allograft Aortic Valve", by M.F. O'Brien, FRACS, G. Stafford, FRACS, M. Gardner, FRACS, P. Pohlner, FRACS, D. McGiffin, FRACS, N. Johnston, FRACPA, A. Brosnan, B.Sc, and P. Duffy, MBBS, PhD, J. Cardiac Surg, vol. 1, No. 3, Supplement, pp. 153-167, 1987.
"Durability of The Viable Aortic Allograft", by W.W. Angell, MD, J.H. Oury, MD, J.J. Lamberti, MD and J. Koziol, PhD, J. Cardiovaic Surg, vol. 98, pp. 48-56, 1989.
"Xenotransplantation: A View to the Future", by F.H. Bach, Transplantation Proceedings, vol. 25, No. 1, pp. 25-29, Feb. 1993.
"New Biologic and Synthetic Vascular Prostheses", by H.P. Greisler, MD, Medical Intelligence Unit, Chapter 3, Biohybrids--Biological Coatings In Synthetic Grafts, pp. 33-46.
"Immunological Aspects of Treated Natural Tis
Colorado State University Research Foundation
Isabella David
LandOfFree
Treated tissue for implantation and methods of treatment and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treated tissue for implantation and methods of treatment and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treated tissue for implantation and methods of treatment and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1854252